Episode Show Notes

For small public companies struggling to raise capital, a convertible note can look like a financial lifeline. But when the conversion price floats with the market, that lifeline can become a trap. In this episode of Inside Securities Law, former SEC enforcement attorney Frederick M. Lehrer explains variable-price convertible notes, commonly called toxic financing, and the dilution spiral that can devastate shareholders and threaten a company's survival.

The mechanism is straightforward but potentially destructive. A company borrows money through a short-term note that allows the lender to convert the debt into common stock at a discount to the market price. As the stock price declines, the lender receives more shares for the same outstanding debt. Those additional shares increase dilution, and selling pressure can contribute to further price declines, triggering another round of conversions at even lower prices. What initially appeared to be an accessible source of working capital can become a cycle of expanding share counts, declining ownership percentages, and increasingly difficult financing conditions.

Lehrer examines why companies accept these arrangements, how variable conversion formulas shift financial risk toward existing shareholders, and why directors and securities counsel must understand the potential consequences before committing to financing terms. The central issue is not simply whether a company can obtain capital, but what that capital will ultimately cost its shareholders.

For executives, directors, investors, and advisers involved with smaller public companies, this episode explains why the details of a convertible note matter long before the first conversion occurs.

About Frederick M. Lehrer

Frederick M. Lehrer is a Florida-based securities attorney and founder of Frederick M. Lehrer, P.A. He served at the U.S. Securities and Exchange Commission from 1984 to 2000, including nine years as an enforcement attorney. Since 2000, he has represented companies in securities offerings, capital raising, SEC reporting, going-public transactions, and corporate governance. His practice emphasizes accurate disclosures, regulatory compliance, and practical securities counsel informed by his experience inside the SEC.

Links and Resources